EpiCept Corporation And Maxim Pharmaceuticals, Inc. Announce Trading And Listing Mechanics Upon Closing Of The Merger

)--Dec. 28, 2005--As previously reported on December 21, 2005 the stockholders of Maxim Pharmaceuticals, Inc. (Maxim) (NASDAQ:MAXM)(SSE:MAXM) approved and adopted the Agreement and Plan of Merger between EpiCept Corporation (EpiCept) and Maxim and approved the merger. EpiCept's stockholders had previously voted to approve the merger agreement and the issuance of the EpiCept common stock to Maxim's stockholders in the merger.